APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 1 filers reported holding APELLIS PHARMACEUTICALS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,963,129 | +67.4% | 50,544 | +188.3% | 0.00% | +100.0% |
| Q1 2023 | $1,172,406 | +135.9% | 17,530 | +61.0% | 0.00% | 0.0% |
| Q2 2022 | $497,000 | -1.4% | 10,887 | +10.1% | 0.00% | 0.0% |
| Q1 2022 | $504,000 | +130.1% | 9,891 | +115.0% | 0.00% | – |
| Q4 2021 | $219,000 | -7.2% | 4,601 | +24.3% | 0.00% | – |
| Q2 2021 | $236,000 | -4.8% | 3,701 | -51.2% | 0.00% | – |
| Q2 2020 | $248,000 | – | 7,580 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 2,503,059 | $170,959,000 | 29.50% |
| ACUTA CAPITAL PARTNERS, LLC | 554,000 | $37,838,000 | 16.29% |
| Avoro Capital Advisors LLC | 10,125,000 | $691,538,000 | 12.78% |
| Sio Capital Management, LLC | 507,700 | $34,676,000 | 11.02% |
| Logos Global Management LP | 1,300,000 | $88,790,000 | 10.92% |
| EcoR1 Capital, LLC | 5,183,431 | $354,028,000 | 10.45% |
| Cormorant Asset Management, LP | 1,478,000 | $100,947,000 | 7.06% |
| Finepoint Capital LP | 266,090 | $18,174,000 | 5.98% |
| Ghost Tree Capital, LLC | 275,000 | $18,783,000 | 5.27% |
| Boxer Capital, LLC | 1,303,700 | $89,043,000 | 5.01% |